Journal Home
Search for

Volume 104, Issue 8, Pages 1189-1196 (August 2010)


View previous. 13 of 21 View next.

Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions

Carlos A. Vaz FragosoabCorresponding Author Informationemail address, John Concatoabemail address, Gail McAvayaemail address, Peter H. Van Nessaemail address, Carolyn L. Rochesterabemail address, H. Klar Yaggiabemail address, Thomas M. Gillaemail address

Received 18 August 2009; accepted 20 October 2009. published online 04 March 2010.

Summary 

Background

Among older persons, we previously endorsed a two-step spirometric definition of chronic obstructive pulmonary disease (COPD) that requires a ratio of forced expiratory volume in 1sec to forced vital capacity (FEV1/FVC) below .70, and an FEV1 below the 5th or 10th standardized residual percentile (“SR-tile strategy”).

Objective

To evaluate the clinical validity of an SR-tile strategy, compared to a current definition of COPD, as published by the Global Initiative for Obstructive Lung Disease (GOLD-COPD), in older persons.

Methods

We assessed national data from 2480 persons aged 65–80 years. In separate analyses, we evaluated the association of an SR-tile strategy with mortality and respiratory symptoms, relative to GOLD-COPD. As per convention, GOLD-COPD was defined solely by an FEV1/FVC<.70, with severity staged according to FEV1 cut-points at 80 and 50 percent predicted (%Pred).

Results

Among 831 participants with GOLD-COPD, the risk of death was elevated only in 179 (21.5%) of those who also had an FEV1<5th SR-tile; and the odds of having respiratory symptoms were elevated only in 310 (37.4%) of those who also had an FEV1<10th SR-tile. In contrast, GOLD-COPD staged at an FEV1 50–79%Pred led to misclassification (overestimation) in terms of 209 (66.4%) and 77 (24.6%) participants, respectively, not having an increased risk of death or likelihood of respiratory symptoms.

Conclusion

Relative to an SR-tile strategy, the majority of older persons with GOLD-COPD had neither an increased risk of death nor an increased likelihood of respiratory symptoms. These results raise concerns about the clinical validity of GOLD guidelines in older persons.

a Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA

b Veterans Affairs (VA) Clinical Epidemiology Research Center, West Haven, CT, USA

Corresponding Author InformationCorresponding author. Internal Medicine, Clinical Epidemiology Research Center, VA Connecticut Healthcare System, Mailcode 151B, West Haven, CT 06516, USA. Tel.: +1 203 688 9423; fax: +1 203 688 4209.

PII: S0954-6111(10)00048-X

doi:10.1016/j.rmed.2009.10.030


View previous. 13 of 21 View next.